slides · global inventory
Evidence
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 40,452
Current window 18,841-18,870
Pages 1,349
Rows per page 30
Beat
18,841-18,870 of 40,452
18
Uses a Good-Better-Best pricing framework combined with product line segmentation.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations Beat · Product1 hit
19
Includes a legend for 2021 new product launches indicated by a dashed blue box.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations Beat · Product1 hit
25
The chart uses a split axis to separate historical annual data from LTM and YTD comparisons.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations Beat · Financials1 hit
26
The slide uses a split-chart layout to compare two key profitability metrics over a multi-year period including LTM and YTD comparisons.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations Beat · Financials1 hit
27
Includes a table for net leverage and a photo of production lines.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations Beat · Financials1 hit
13
The slide highlights BioNTech's global reach and commitment to equitable access.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Includes clinical trial data for BNT162b2 vs placebo.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
Includes a dot plot for antibody titers, a sequence alignment table for T-cell epitopes, and a summary table for real-world effectiveness.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
17
The slide uses a numbered process flow combined with a data table to show clinical trial progression.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
Includes two sets of bar charts comparing neutralizing titers across age groups and vaccine doses.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
19
BioNTech | Results Presentation Deck | 43 slidesBioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
20
The slide uses a hub-and-spoke style diagram to illustrate how different therapeutic modalities (mRNA, CAR-T, Antibodies, Small Molecules, Engineered Biologicals) contribute to two main strategic pillars: Targeting Cancer and Immunomodulation.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
21
The slide uses a timeline-like visual representation for clinical phases.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
22
The slide uses a combination of a conceptual process diagram and flow cytometry data plots to validate the mechanism of action.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
23
The slide uses a combination of quantitative metrics and qualitative clinical context to establish the problem.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
24
Includes a citation to a Nature publication and a visual representation of the mRNA construct.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
25
Clinical trial design diagram showing randomization of 120 patients into three arms.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · ProductLoop · Golden Circle1 hit
35
The table shows a significant increase in commercial revenues and operating profit compared to the prior year.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · TeamLoop · Golden Circle1 hit
36
The chart uses a stacked bar format to decompose revenue into four categories, with a specific focus on COVID-19 vaccine revenue.BioNTech | Results Presentation Deck | 43 slides · BioNTech
Conference presentation Investor relations Beat · TeamLoop · Golden Circle1 hit
05
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
06
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
07
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
08
Blue Apron | Results Presentation Deck | 17 slidesBlue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
09
The slide compares revenue and marketing spend trends over five quarters, highlighting the impact of pandemic-related demand fluctuations.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
10
Includes YoY growth percentages for each metric and detailed footnotes defining the metrics.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
11
PTG&A likely stands for Pre-opening, Technology, General & Administrative expenses.Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
12
The slide compares financial performance across five quarters (Q2'20 to Q2'21).Blue Apron | Results Presentation Deck | 17 slides · Blue Apron
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
03
The slide uses a donut chart to visualize the AUM composition.Carlyle | Investor Conference Presentation Deck | 41 slides · Carlyle
Conference presentation Investor relations Beat · Market Size1 hit
04
The slide uses a three-column layout to highlight key financial KPIs.Carlyle | Investor Conference Presentation Deck | 41 slides · Carlyle
Conference presentation Investor relations Beat · Market Size1 hit